New study tests migraine drug in everyday life
NCT ID NCT06692881
First seen Jan 06, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This study looks at how well the migraine drug ubrogepant helps adults in Canada function during and after a migraine attack, and how satisfied they are with the treatment. About 167 participants will take the drug as prescribed by their doctor and be followed for up to 12 weeks. The goal is to see if the drug helps them get back to normal activities quickly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
360 Concussion Care /ID# 271972
Ottawa, Ontario, K1H 7X7, Canada
-
Bayshore Neurology /ID# 280213
Ottawa, Ontario, K2B 8E8, Canada
-
Burrard Health Center /ID# 271474
Vancouver, British Columbia, V6Z 2E8, Canada
-
Calgary Headache Assessment and Management Program /ID# 271475
Calgary, Alberta, T3M 1M4, Canada
-
Centre de Recherche St-Louis /ID# 272843
Lévis, Quebec, G6W 0M5, Canada
-
Centricity /ID# 271477
London, Ontario, N6A 2C2, Canada
-
Diex Recherche Sherbrooke /ID# 271677
Sherbrooke, Quebec, J1L 0H8, Canada
-
Genge Partners /ID# 273302
Montreal, Quebec, H4A 3T2, Canada
-
London Health Sciences Centre - Victoria Hospital & Children's Hospital /ID# 272031
London, Ontario, N6A 5W9, Canada
-
Maritime Neurology /ID# 271867
Halifax, Nova Scotia, B3R 1V9, Canada
-
Neurocentre of Eastern Ontario /ID# 271865
Kingston, Ontario, K7M 8H9, Canada
-
Royal Jubilee Hospital /ID# 271476
Victoria, British Columbia, V8R 1J8, Canada
-
Sunnybrook Health Sciences Centre /ID# 276844
Toronto, Ontario, M4N 3M5, Canada
Conditions
Explore the condition pages connected to this study.